CN1058154C - Medicine for treatment of pile - Google Patents
Medicine for treatment of pile Download PDFInfo
- Publication number
- CN1058154C CN1058154C CN 93110642 CN93110642A CN1058154C CN 1058154 C CN1058154 C CN 1058154C CN 93110642 CN93110642 CN 93110642 CN 93110642 A CN93110642 A CN 93110642A CN 1058154 C CN1058154 C CN 1058154C
- Authority
- CN
- China
- Prior art keywords
- medicine
- treatment
- present
- hemorrhoid
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses medicine for treating hemorrhoids, which comprises the effective components with the optimal proportion: 5 to 25 wt% of sodium citrate, 2 to 20 wt% of alum, 2 to 20 wt% of acetic acid and a surplus carrier. The total effective rate of the medicine for treating internal hemorrhoids reaches 97.44%. In addition, the present invention has the advantages of small use dose, mild pain, quick hemostasis, short cure time, simple and convenient clinical use, etc.
Description
The present invention relates to a kind of medicine for the treatment of hemorrhoid, particularly be applicable to the medicine of treatment internal hemorrhoid.
Hemorrhoid are diseases of a kind of common pilosity, and the Therapeutic Method of employing is also more, and wherein Drug therapy is with injection drug curative effect the best.At present the injection drug of most common treatment is " xiaozhiling injection " of the development of Gate of Pervasive Peace hospital of Beijing academy of traditional Chinese medicine clinically, is 95.5% to the effective percentage of internal hemorrhoid treatment.But this medicine injection shot is big, needs 15-20ml, the patient suffering big and the time have complication to take place.
The object of the present invention is to provide a kind of therapeutic effect better, shot consumption is few, and the patient suffering is few and have no side effect and the medicine of the treatment hemorrhoid of complication.
The object of the present invention is achieved like this: this effective elements of the medicine comprises sodium citrate, Alumen, acetic acid.
Its proportioning is preferably: sodium citrate 5-25 weight %, Alumen 2-20 weight %, acetic acid 2-20 weight %, carrier are made injection type with water the best.When carrier is oil or vaseline, also can be made into putty-type.
Injecting drug use of the present invention is a colourless transparent solution, during treatment medicine is directly injected blood stasis tela submucosa, and the blood stasis atrophy is come off, and consumption can be grasped according to the blood stasis size, and generally each blood stasis dosage only needs 0.2-0.5ml to get final product.
Through clinical practice and processing by statistics, show that this medicine can reach 100% to the cure rate of initial stage internal hemorrhoid, total effective rate reaches 97.44%, is better than " xiaozhiling injection " and other medicines.Only need a pin to stop blooding to Internal hemorrhoid hemorrhage.
Because active ingredient of the present invention is all nontoxic, non-stimulated, and use amount 0.2-0.5ml only, so patient is painful few, the 5-10 hypodynia of second is only arranged after the injection, and without any side effects and complication generation.Use also easy patient only can fully recover, need not to be in hospital with a door rash several times.
Embodiment 1
Sodium citrate 15 grams, Alumen 50 grams, adding distil water 500ml, heating for dissolving adds 36% acetic acid 200ml, is settled to 1000ml with distilled water, and the ampoule bottle of packing into is made every bottle of 0.5ml injection.
Claims (2)
1, a kind of medicine for the treatment of hemorrhoid, it is characterized in that the each component composition and the proportioning of this medicine is: sodium citrate 5-25 weight %, Alumen 2-20 weight %, acetic acid 2-20 weight %, surplus are carrier.
2, according to the medicine of the described treatment hemorrhoid of claim 1, it is characterized in that: the carrier of this medicine is a water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110642 CN1058154C (en) | 1993-03-27 | 1993-03-27 | Medicine for treatment of pile |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110642 CN1058154C (en) | 1993-03-27 | 1993-03-27 | Medicine for treatment of pile |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1092655A CN1092655A (en) | 1994-09-28 |
| CN1058154C true CN1058154C (en) | 2000-11-08 |
Family
ID=4988485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93110642 Expired - Fee Related CN1058154C (en) | 1993-03-27 | 1993-03-27 | Medicine for treatment of pile |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058154C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09143079A (en) * | 1995-11-21 | 1997-06-03 | Chiyuuyakuken:Kk | External preparation for treatment of lesional abnormal tissue |
| JPH09227383A (en) * | 1996-02-23 | 1997-09-02 | Chiyuuyakuken:Kk | Suppository for treating rectum lesion tissue |
| CN1067569C (en) * | 1997-11-12 | 2001-06-27 | 内蒙古医学院 | Zhixuening-medicine for stopping bleeding |
| CN112494497A (en) * | 2020-12-22 | 2021-03-16 | 唐凌文 | Compound liquid preparation and preparation method and application thereof |
-
1993
- 1993-03-27 CN CN 93110642 patent/CN1058154C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1092655A (en) | 1994-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20080031394A (en) | Pharmaceutical compositions comprising a tgf-beta superfamily member | |
| CN1141929C (en) | Medicament and method of treating an organism with medicaments | |
| JP2001510795A5 (en) | ||
| RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
| CN1058154C (en) | Medicine for treatment of pile | |
| TWI646971B (en) | Some prescriptions for blocking the path of heroin or morphine drug poisoning and their application | |
| US6623732B1 (en) | Pharmaceutical formulation for nasal administration | |
| JPH08512311A (en) | Arsenic medicine for treating chronic fatigue syndrome | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| RU2009116629A (en) | Azithromycin for the treatment of nodular acne | |
| CN1200942A (en) | Interferon liposome jellies | |
| RU1803119C (en) | Method of extrauterine pregnancy treatment | |
| RU2356557C2 (en) | Homeopathic medicine for treatment and prevention of endometritis in animals | |
| SU1706624A1 (en) | Method for curing opiumism and morphinism | |
| JPS6229529A (en) | Manufacture of medicine for disease | |
| CN1117563C (en) | Analgesic composition for cancers in digestive system | |
| Watson | Effects of concurrent drug therapy and of feeding on plasma chloramphenicol levels after oral administration of chloramphenicol in dogs | |
| Hartmann et al. | Unanticipated side effects from treatment with high dose mechlorethamine in patients with malignant melanoma | |
| RU2147882C1 (en) | Method for preventing pregnancy | |
| JPS60174726A (en) | Pharmaceutical composition for injection | |
| CN116327746A (en) | Application of isoliquiritigenin in preparation of medicine for preventing or treating drug-induced liver injury caused by acetaminophen | |
| CN1252294A (en) | External-use medicine for women and its production process | |
| RU2258520C2 (en) | Method for treating stem ischemic insult | |
| CN1117855A (en) | Injection for treating haemorrhoids and fistulae and production method thereof | |
| HRP20020201A2 (en) | Pharmaceutical compositions for treating psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |